Oncocyte Corporation (NASDAQ: OCX)
$3.40
+0.0400 ( +1.19% ) 28.9K
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
Market Data
Open
$3.40
Previous close
$3.36
Volume
28.9K
Market cap
$43.97M
Day range
$3.26 - $3.40
52 week range
$2.08 - $4.64
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Jul 12, 2024 |
8-k | 8K-related | 13 | Jul 05, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
3 | Insider transactions | 1 | Jun 24, 2024 |
4 | Insider transactions | 2 | Jun 24, 2024 |
8-k | 8K-related | 14 | Jun 17, 2024 |
8-k | 8K-related | 13 | May 31, 2024 |
8-k | 8K-related | 13 | May 23, 2024 |